Adam Hanina is CEO of AiCure, a venture and NIH-funded company that has developed artificial intelligence to visually confirm medication ingestion by clinical trial participants and high-risk patients. He is a passionate advocate for the use of healthcare software as a population health tool and has directed much of his previous work to this end.
Prior to AiCure, Mr. Hanina was responsible for further development of Cerner Corporation’s European strategy and was a Visiting Fellow of eHealth at Imperial College in London, UK. Mr. Hanina has spoken extensively on the topic of healthcare innovation and has held numerous advisory board positions including for the Indian High Commission’s Healthcare, Pharmaceutical, & Biotech Committee, and for Deloitte Consulting’s Health Informatics Network for Europe (HINE).
Adam has been responsible for much of the vision and strategy at AiCure and is the primary inventor of the patented technology. He has acted as a subject-matter expert on medication adherence technologies for the National Institutes of Health (NIH) and is currently a principal investigator for multiple NIH innovation grants. He holds an MBA from the Wharton School of Business.